probucol has been researched along with Hepatoblastoma in 1 studies
Probucol: A drug used to lower LDL and HDL cholesterol yet has little effect on serum-triglyceride or VLDL cholesterol. (From Martindale, The Extra Pharmacopoeia, 30th ed, p993).
probucol : A dithioketal that is propane-2,2-dithiol in which the hydrogens attached to both sulfur atoms are replaced by 3,5-di-tert-butyl-4-hydroxyphenyl groups. An anticholesteremic drug with antioxidant and anti-inflammatory properties, it is used to treat high levels of cholesterol in blood.
Hepatoblastoma: A malignant neoplasm occurring in young children, primarily in the liver, composed of tissue resembling embryonal or fetal hepatic epithelium, or mixed epithelial and mesenchymal tissues. (Stedman, 25th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pico, I | 1 |
| Myara, I | 1 |
| Pech-Amsellem, MA | 1 |
| Vedie, B | 1 |
| Chappey, B | 1 |
| Moatti, N | 1 |
1 other study available for probucol and Hepatoblastoma
| Article | Year |
|---|---|
Oxidative modification of low-density lipoprotein by the human hepatoma cell line HepG2.
Topics: Antioxidants; Butylated Hydroxytoluene; Chromatography, Ion Exchange; Electrophoresis, Agar Gel; Ele | 1996 |